Delivery Order 75N95023D00007-75N95023F00002
- This is a firm fixed-price delivery order awarded by the National Institute of Mental Health (NIMH) to the New York Genome Center, Inc. (NYGC) for Task Area 1: Manual of Operations under the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core contracts. The contract has a ceiling value of $38,000.00 and an ultimate completion date of May 13, 2025. NYGC, a non-profit academic research institution, will provide specialized genomic sequencing and analysis services to support the BRAIN...
- This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
- This is a $274,036 fixed-price task order awarded to the New York Genome Center, Inc. (Nygc) by the National Cancer Institute (NCI) under the NCI Genomic Characterization Centers master IDIQ contract. The purpose is to provide DNA methylation arrays to support new studies by the Cancer Genomics Program over a 3-year period of performance from September 2020 to September 2023. This task order is fully funded and non-severable. Nygc is a nonprofit academic research institution that provides...
- This federal contract award is for Next Generation Sequencing services in support of an ongoing research study. The contract was awarded to the New York Genome Center, Inc. (Nygc), a non-profit academic research institution specializing in advanced genomic sequencing, analysis, and computational services for federal agencies. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $26,020 and a period of performance through November 30, 2025. The funding agency is the...
- This is a $112,860 definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for sequencing services to support the VA's research study on "Epigenetic Mechanisms in Blast Related Traumatic Brain Injury". NYGC has previously performed this work and the VA determined that continuing with NYGC is essential to avoid...
- This is a delivery order award to the New York Genome Center, Inc. (doing business as Nygc), a nonprofit academic research institution, under the Centralized Omic REsource for TOPMed (CORE) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute (NHLBI). The order, valued at $5,906,039.00, is for the fifth year of the Centralized Omics Resource (CORE) project, which provides centralized omics data analysis and management services to support...
- This is a $61,697.50 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 2 to the nonprofit New York Genome Center, Inc. (doing business as Nygc) for sequencing services. The award does not have a set-aside designation. Nygc is a leading academic research institution that specializes in genomic sequencing, analysis, and computational services for federal agencies. It has delivered these services to various NIH institutes as well...
- This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, for a Single Cell Sequencing Task Order under the NCI Genomic Characterization Centers master IDIQ contract. The period of performance is from September 16, 2019 to September 15, 2022, with a ceiling value of $190,664.68. The order is in support of NCI's Center for Cancer Genomics program and does not have a set-aside...
- This is a $3,695,082 delivery order contract awarded by the National Heart, Lung and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC) for the NHLBI Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) program. The contract has a completion date of September 22, 2026 and uses a firm fixed price pricing model. NYGC is a non-profit organization that specializes in advanced genomic sequencing, analysis, and computational services for federal agencies....
- This federal contract award is for the Trans-Omics for Precision Medicine (TOPMed) for the Centralized Omics Resource (CORE) - RNA-Seq project in 2024, issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency. The prime contractor is the New York Genome Center, Inc. (NYGC), a non-profit academic research institution. The contract has a ceiling value of $7,001,570.38 and is a firm fixed-price delivery order with a period of performance through September 2026. NYGC has...
- 75N95023D00007Indefinite Delivery Contract
- 75N95023D00007-75N95023F00002Delivery Order
This is a federal contract award to New York Genome Center, Inc. (Nygc), a nonprofit academic research institution, by the National Institute of Mental Health (NIMH), a civilian agency. The $73,817,033 contract is a delivery order under the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core master IDIQ, which Nygc holds. Under this contract, Nygc will provide specialized genomic sequencing and analysis services to support major federal biomedical research initiatives. The contract does not have a set-aside designation, reflecting the specialized nature of Nygc's genomic services. Nygc has a history of delivering next-generation sequencing, whole genome sequencing, RNA sequencing, and other genomic characterization services to federal agencies including the Department of Veterans Affairs, National Institutes of Health, and its institutes like the National Cancer Institute and National Heart, Lung and Blood Institute.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $8.7m | 5/28/25 | |
| P00001 | Exercise an Option | $9.0m | 5/17/24 | |
| Not listed | Not listed | $9.0m | 5/26/23 |